4.3 Review

Polyhydroxyalkanoates (PHA) for therapeutic applications

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.msec.2017.12.035

Keywords

PHA; Therapeutics; Tissue engineering; Implants; Drug delivery; Biomedicine

Funding

  1. Ministry of Sciences and Technology [2016YFB0302504]
  2. National Natural Science Foundation of China [31430003, 31600072, 81503079]
  3. Natural Science Foundation of Jiangxi Province [20161BAB215204]
  4. Russian Science Foundation [17-15-01352]
  5. Tsinghua President Fund [2015THZ10]
  6. Russian Science Foundation [17-15-01352] Funding Source: Russian Science Foundation

Ask authors/readers for more resources

As intracellular carbon and energy storage materials, polyhydroxyalkanoates (PHA) are a diverse biopolyesters synthesized by many bacteria. PHA have been produced in large quantity for various application research including medical implants for approximately 30 years. Many studies demonstrated that PHA are promising implant materials due to their diverse and ascendant mechanical, biodegradable and tissue compatible properties. Importantly, common PHA biodegradation products including oligomers and monomers are also not toxic to the cells and tissues. Pharmaceutical applications of some PHA degradation products also have been reported. So far, no study has been reported to have any carcinogenesis result induced by any PHA or their biodegradation products. All results suggest that PHA could be developed into various bio-implant products.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available